PRICA, Anca
$52,917.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada
Phase II trial of Azacitidine plus Deferasirox in higher risk Myelodysplastic Syndromes (MDS)